$BMA

Banco Macro Shareholders Approve 2025 Results and AR$147 Billion Dividend Plan

Banco Macro shareholders approved the 2025 financial statements, board performance, and a significant AR$147 billion dividend plan. They also allocated AR$290.44 billion to reserves and refreshed director and oversight bodies for 2026. Spark, TipRanks’ AI Analyst, rates BMA as Neutral, highlighting strong revenue growth and a solid balance sheet, but tempered by modest profitability and concerns from the recent earnings call.

Original reporting
TipRanks · TipRanks Auto-Generated Newsdesk
Published Apr 10, 2026, 10:33 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 10, 2026, 11:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Banco Macro Shareholders Approve 2025 Results and AR$147 Billion Dividend Plan — source image
Decision brief

The 30-second read

$BMANeutralMed
01

Why it matters

The approval of a substantial dividend and reserve allocations suggests a focus on shareholder returns and financial stability, potentially attracting income-focused investors.

02

Market read

The news is relevant for investors interested in regional banking stocks, especially those seeking dividend income and financial stability indicators.

03

What to watch

Potential macroeconomic shifts or regulatory changes could impact future performance, which are not addressed in this analysis.

Timing: Immediate, as the news is recent and pertains to upcoming dividend distributions.

Background

Banco Macro shareholders approved the 2025 financial statements, dividend plan, and corporate governance updates, reflecting confidence in the company's strategic direction.

Company-level read

Ticker impact

$BMANeutralMedium confidence
Context

The news pertains directly to Banco Macro, impacting its financial outlook and dividend policy.

Expected impact

Moderate upward movement expected in the short term, contingent on dividend realization and market sentiment.

Evidence & confidence

The approval of dividends and reserves indicates confidence in the company's financial health, likely supporting stock price. However, modest profitability and earnings concerns introduce some uncertainty.

Market effects

Potential positive impact on the banking sector due to increased dividend payouts and financial stability.

Limited, as Banco Macro's operations are primarily regional, with minimal influence on broader regional markets.

Negligible, given the company's regional focus and the nature of the news.

Counterpoint

The dividend approval may be priced in already, and modest profitability could lead to limited upside or potential downside if earnings disappoint.

Key entities

  • Banco Macro

    A regional bank operating primarily in Argentina, with a focus on retail banking and financial services.

Related articles

$BMAMed

Banco Macro Announces Results for the Second Quarter of 2026

Banco Macro reported 2Q26 net income of Ps.206.8 billion, up 39% from the previous quarter and 4% year-over-year. Operating income before expenses was Ps.1.29 trillion, down 2% quarter-over-quarter but up 1% year-over-year. The bank's total financing increased 3% quarter-over-quarter but decreased 5% year-over-year. Banco Macro maintains strong solvency and liquidity ratios, with excess capital of Ps.4.1 trillion and liquid assets covering 74% of deposits.

$BMAHigh

Macro Bank Inc. (BMA): Financial results for Q2 2026

Macro Bank Inc. (BMA) furnished an SEC Form 6-K — earnings release. Yes o No x 2Q26 Earnings Release AUGUST 19TH, 2026 BANCO MACRO 2Q26 EARNINGS RELEASE 2 Index 01 Summary 02 Disclaimer 03 Results 04 Financial Assets 05 Public Sector Assets 06 Funding 07 Liquid Assets 08 Solvency 09 Asset Quality 10 2Q26 Snapshot 11 Relevant and Recent Events 12

$BMAMedAI 8/10

Banco Macro Q1 2026 Earnings Call Transcript - Banco Macro (NYSE:BMA)

Banco Macro reported Q1 2026 net income of 139.8 billion pesos, up 28% quarter-on-quarter and 131% year-on-year, according to the earnings call transcript. Operating income before expenses fell 3% vs. Q4 2025 but rose 15% year-on-year. The bank kept 2026 loan growth guidance at 42% nominal and deposit growth at 34% nominal, assuming 28% inflation. NPL ratio was 5.4% with ~110% coverage; cost of risk guidance is 5.5%–6%.

$BKRMed

Baker Hughes (BKR) Secures Order For 76 Gas Turbines

Baker Hughes (BKR) secured an order for 76 NovaLT™16 gas turbines from Dynamis Power Solutions, valued at 1.3 GW, for hypermobile power projects. The turbines are designed for rapid deployment in data centers and oil and gas operations, aligning with Baker Hughes' focus on distributed power and digital infrastructure. Analysts view this as part of the company's strategy for higher-margin, recurring revenue streams.

$AMGNLowAI 8/10

Evolocumab before PCI for acute MI improves LDL control

Amgen's evolocumab (Repatha) improved LDL control in acute MI patients by 1 year when administered early, but did not impact clinical outcomes vs. standard care, according to the AMUNDSEN trial presented at the European Society of Cardiology Congress and published in JAMA. 82% of patients on evolocumab met LDL targets vs. 40% on standard care alone.